Učitavanje...
Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance
PURPOSE: To investigate whether tolerance to the anti-VEGF drug, ranibizumab, develops after drug exposure and to determine whether the history of treatment with ranibizumab prior to refractoriness can predict the post-switching responses to aflibercept. METHODS: We retrospectively investigated neov...
Spremljeno u:
| Izdano u: | Clin Ophthalmol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5880512/ https://ncbi.nlm.nih.gov/pubmed/29636594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S160367 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|